Monitoring the Biological Response to Anifrolumab in Real World Setting Using Interferon Gene Signature Shows Signs of Therapy Resistance in Select SLE Patients (ACR Convergence 2026) - Sep 8, 2026 - Abstract #2261; Pres time: Nov 10, 2026; 10:30 AM - 12:30 PM; Location: WB1&2; In Person; No abstract available
Clinical • Gene Signature • Real-world • Real-world evidence • Inflammatory Arthritis
|